These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6213192

  • 1. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci.
    Cynamon MH, Granato PA.
    Antimicrob Agents Chemother; 1982 Mar; 21(3):504-5. PubMed ID: 6213192
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.
    Tuazon CU, Miller H.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):411-2. PubMed ID: 6233934
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G.
    Chemotherapy; 1983 Apr; 29(4):275-82. PubMed ID: 6223793
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1982 Oct; 1(5):278-81. PubMed ID: 6223812
    [Abstract] [Full Text] [Related]

  • 5. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Oct; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Oct; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
    Greenwood D, Bidgood K, Turner M.
    J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
    [Abstract] [Full Text] [Related]

  • 8. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y, Hasçelik G, Gür D, Akalin E.
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.
    Varaldo PE, Debbia E, Schito GC.
    Antimicrob Agents Chemother; 1983 Mar; 23(3):402-6. PubMed ID: 6221692
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
    Schwalbe RS, McIntosh AC, Qaiyumi S, Johnson JA, Johnson RJ, Furness KM, Holloway WJ, Steele-Moore L.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2416-9. PubMed ID: 8891155
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
    Jansen B, Schumacher-Perdreau F, Pulverer G.
    Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A, Korzeniewski K, Nitsch-Osuch A, Rybicki Z, Prokop E.
    Adv Exp Med Biol; 2013 Oct; 788():125-32. PubMed ID: 23835969
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G, Pirali F, Foresti I, Turano A.
    Drugs Exp Clin Res; 1987 Oct; 13(4):225-9. PubMed ID: 2957187
    [Abstract] [Full Text] [Related]

  • 14. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, Scotti R, Arioli V.
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [Abstract] [Full Text] [Related]

  • 15. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 16. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.
    Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2059-62. PubMed ID: 10428937
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Biavasco F, Lupidi R, Varaldo PE.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):331-8. PubMed ID: 1534977
    [Abstract] [Full Text] [Related]

  • 19. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D, Brown DF, Soussy CJ.
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S, Tebbs SE, Elliott TS.
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.